JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Activity
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichise, M.
Right arrow Articles by Yonekura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichise, M.
Right arrow Articles by Yonekura, Y.
Journal of Nuclear Medicine Vol. 42 No. 5 755-763
© 2001 by Society of Nuclear Medicine


CONTINUING EDUCATION

An Introduction to PET and SPECT Neuroreceptor Quantification Models*

Masanori Ichise, Jeffrey H. Meyer and Yoshiharu Yonekura

Molecular Imaging Branch, National Institute of Mental Health, Bethesda, Maryland; PET Imaging Center, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; and Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan

PET and SPECT using appropriate radioligands allow imaging of certain critical components of neurotransmission such as presynaptic transporters and postsynaptic receptors in living human brains. PET and SPECT data are commonly analyzed by applying tracer kinetic models. These modeling approaches assume a compartmental system and derive the outcome measure called the binding potential, which reflects the densities of transporters or receptors in a brain region of interest. New models are often noninvasive in that they do not require arterial blood sampling. In this review, the concept and principles of tracer kinetic modeling are introduced and commonly used PET and SPECT neuroreceptor quantification models are discussed.

Key Words: PET • SPECT • neuroreceptors • kinetic modeling • receptor quantification




This article has been cited by other articles:


Home page
BrainHome page
G. Henriksen and F. Willoch
Imaging of opioid receptors in the central nervous system
Brain, May 1, 2008; 131(5): 1171 - 1196.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. A. Hammoud, J. M. Hoffman, and M. G. Pomper
Molecular Neuroimaging: From Conventional to Emerging Techniques
Radiology, October 1, 2007; 245(1): 21 - 42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
D. Mamo, A. Graff, R. Mizrahi, C. M. Shammi, F. Romeyer, and S. Kapur
Differential Effects of Aripiprazole on D2, 5-HT2, and 5-HT1A Receptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET Study
Am J Psychiatry, September 1, 2007; 164(9): 1411 - 1417.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. Le Foll, S. I. Chefer, A. S. Kimes, D. Shumway, S. R. Goldberg, E. A. Stein, and A. G. Mukhin
Validation of an Extracerebral Reference Region Approach for the Quantification of Brain Nicotinic Acetylcholine Receptors in Squirrel Monkeys with PET and 2-18F-Fluoro-A-85380
J. Nucl. Med., September 1, 2007; 48(9): 1492 - 1500.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Mintun, G. N. LaRossa, Y. I. Sheline, C. S. Dence, S. Y. Lee, R. H. Mach, W. E. Klunk, C. A. Mathis, S. T. DeKosky, and J. C. Morris
[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Neurology, August 8, 2006; 67(3): 446 - 452.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. L. Brody, M. A. Mandelkern, E. D. London, R. E. Olmstead, J. Farahi, D. Scheibal, J. Jou, V. Allen, E. Tiongson, S. I. Chefer, et al.
Cigarette Smoking Saturates Brain {alpha}4beta2 Nicotinic Acetylcholine Receptors.
Arch Gen Psychiatry, August 1, 2006; 63(8): 907 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Ichise, D. C. Vines, T. Gura, G. M. Anderson, S. J. Suomi, J. D. Higley, and R. B. Innis
Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys.
J. Neurosci., April 26, 2006; 26(17): 4638 - 4643.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
R. Thomasius, P. Zapletalova, K. Petersen, R. Buchert, B. Andresen, L. Wartberg, B. Nebeling, and A. Schmoldt
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective
J Psychopharmacol, March 1, 2006; 20(2): 211 - 225.
[Abstract] [PDF]


Home page
JNMHome page
R. M. Baldwin
Imaging MAO-A Levels by PET Using the Deuterium Isotope Effect
J. Nucl. Med., September 1, 2005; 46(9): 1411 - 1413.
[Full Text] [PDF]


Home page
AJGPHome page
N. P.L.G. Verhoeff, A. A. Wilson, S. Takeshita, L. Trop, D. Hussey, K. Singh, H. F. Kung, M.-P. Kung, and S. Houle
In-Vivo Imaging of Alzheimer Disease {beta}-Amyloid With [11C]SB-13 PET
Am J Geriatr Psychiatry, December 1, 2004; 12(6): 584 - 595.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K.-J. Lin, T.-C. Yen, S.-P. Wey, J.-J. Hwang, X.-X. Ye, K.-Y. Tzen, Y.-K. Fu, and J.-C. Chen
Characterization of the Binding Sites for 123I-ADAM and the Relationship to the Serotonin Transporter in Rat and Mouse Brains Using Quantitative Autoradiography
J. Nucl. Med., April 1, 2004; 45(4): 673 - 681.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.